Antibody deficiency secondary to chronic lymphocytic leukemia: Should patients be treated with prophylactic replacement immunoglobulin?

Antibody deficiency secondary to chronic lymphocytic leukemia: Should patients be treated with prophylactic replacement immunoglobulin?

Show other versions (1)

Hypogammaglobulinemia is a common finding in chronic lymphocytic leukemia (CLL). Its incidence increases with disease duration and stage such that it is present in up to 85 % of patients at some point in their disease course. It is therefore important to monitor patients for the development of an an...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak:	Dhalla, F, Lucas, M, Schuh, A, Bhole, M, Jain, R, Patel, S, Misbah, S, Chapel, H
Formatua:	Journal article
Hizkuntza:	English
Argitaratua:	2014

Antzeko izenburuak

Antibody deficiency secondary to chronic lymphocytic leukemia: Should patients be treated with prophylactic replacement immunoglobulin?
nork: Dhalla, F, et al.
Argitaratua: (2014)

Streptococcus pneumoniae pericarditis in a patient with primary antibody deficiency and multiple complications
nork: Bhole, M, et al.
Argitaratua: (2008)

When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency: a practical approach
nork: Jolles, S, et al.
Argitaratua: (2016)

Self-infusion programmes for immunoglobulin replacement at home: feasibility, safety and efficacy.
nork: Bhole, M, et al.
Argitaratua: (2008)

Should treatment of hypogammaglobulinemia with immunoglobulin replacement therapy (IgRT) become standard of care in patients with chronic lymphocytic leukemia?
nork: Alessandro Noto, et al.
Argitaratua: (2023-04-01)

Subcutaneous immunoglobulins replacement therapy in secondary antibody deficiencies: Real life evidence as compared to primary antibody deficiencies.
nork: Francesco Cinetto, et al.
Argitaratua: (2021-01-01)

Differential immunomodulation of T-cells by immunoglobulin replacement therapy in primary and secondary antibody deficiency.
nork: Tri Dinh, et al.
Argitaratua: (2019-01-01)

A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency
nork: Andrea Visentin, et al.
Argitaratua: (2022-12-01)

Primary antibody deficiency in adults.
nork: Spickett, G, et al.
Argitaratua: (1991)

Use of intravenous immunoglobulin in chronic lymphocytic leukemia. A brief review.
nork: Dicato, M, et al.
Argitaratua: (1991)

Immunoglobulin replacement therapy for primary immunodeficiencies.
nork: Peter, J, et al.
Argitaratua: (2014)

Efficacy of immunoglobulin replacement therapy and azithromycin in severe asthma with antibody deficiency
nork: Angelica Tiotiu, et al.
Argitaratua: (2020-04-01)

Immunoglobulin replacement in chronic lymphocytic leukaemia.
nork: Bunch, C
Argitaratua: (1988)

Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. A randomized, controlled clinical trial. Cooperative Group for the Study of Immunoglobulin in Chronic Lymphocytic Leukemia.
nork: Gamm, H, et al.
Argitaratua: (1988)

Subcutaneous immunoglobulin replacement for treatment of humoral immune dysfunction in patients with chronic lymphocytic leukemia
nork: S. Shahzad Mustafa, et al.
Argitaratua: (2021-01-01)

Immunoglobulin replacement in patients with chronic lymphocytic leukaemia: a comparison of two dose regimes.
nork: Chapel, H, et al.
Argitaratua: (1994)

Subcutaneous immunoglobulin replacement therapy: the European experience.
nork: Chapel, H, et al.
Argitaratua: (2013)

P603: INFECTIONS BEFORE AND DURING IMMUNOGLOBULIN REPLACEMENT THERAPY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA.
nork: Christian Brieghel, et al.
Argitaratua: (2023-08-01)

Immunoglobulin replacement therapy by self-infusion at home.
nork: Chapel, H, et al.
Argitaratua: (1988)

Prospective audit of adverse reactions occurring in 459 primary antibody-deficient patients receiving intravenous immunoglobulin.
nork: Brennan, V, et al.
Argitaratua: (2003)

Clinical profile associated with infections in patients with chronic lymphocytic leukemia. Protective role of immunoglobulin replacement therapy
nork: Andrea Visentin, et al.
Argitaratua: (2015-12-01)

Immunoglobulin Replacement Therapy for Hypogammaglobulinemia in Multiple Myeloma Should Not Be Ignored
nork: Qinggang Zhang, et al.
Argitaratua: (2024-03-01)

Rational use of immunoglobulins (IVIgs and SCIgs) in secondary antibody deficiencies
nork: Jeroen S. Goede, et al.
Argitaratua: (2024-09-01)

Contribution of immunoglobulin products in influencing seasonal influenza infection and severity in antibody immune deficiency patients receiving immunoglobulin replacement therapy
nork: Mark Ballow, et al.
Argitaratua: (2024-10-01)

Selective Immunoglobulins deficiency in relatives antibody deficiency patient
nork: Yralys Naranjo Herrera, et al.
Argitaratua: (2025-02-01)

Challenges in the role of gammaglobulin replacement therapy and vaccination strategies for hematological malignancy
nork: Sánchez-Ramón, S, et al.
Argitaratua: (2018)

Consensus on diagnosis and management of primary antibody deficiencies. Consensus Panel for the Diagnosis and Management of Primary Antibody Deficiencies.
nork: Chapel, H
Argitaratua: (1994)

Ten-year population trends of immunoglobulin use, burden of adult antibody deficiency and feasibility of subcutaneous immunoglobulin (SCIg) replacement in Hong Kong Chinese
nork: Andy Ka Chun Kan, et al.
Argitaratua: (2022-12-01)

Immunomodulatory effects of different intravenous immunoglobulin preparations in chronic lymphocytic leukemia
nork: Ana Colado, et al.
Argitaratua: (2021-06-01)

Nanopore sequencing approach for immunoglobulin gene analysis in chronic lymphocytic leukemia
nork: Crescenzio Francesco Minervini, et al.
Argitaratua: (2021-09-01)

Immunoglobulin replacement therapy in secondary hypogammaglobulinemia
nork: Nicolò eCompagno, et al.
Argitaratua: (2014-12-01)

Infection Outcomes in Relation to Immunoglobulin Therapy for Common Variable Immunodeficiency Disorders Over 22 Years
nork: Lucas, M, et al.
Argitaratua: (2010)

Clinical outcomes of immunoglobulin treatment for patients with secondary antibody deficiency: Data from the Ontario immunoglobulin treatment case registry.
nork: Armin Abadeh, et al.
Argitaratua: (2023-01-01)

Clinical outcomes of immunoglobulin treatment for patients with secondary antibody deficiency: Data from the Ontario immunoglobulin treatment case registry
nork: Armin Abadeh, et al.
Argitaratua: (2023-01-01)

HYPER IMMUNOGLOBULIN E IGE SYNDROME (HIES) WITH PARTIAL T LYMPHOCYTES DEFICIENCY
nork: Muhammad Hussain, et al.
Argitaratua: (2019-04-01)

The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy
nork: Bjorkander, J, et al.
Argitaratua: (2000)

Current Practice and Perspectives on Subcutaneous Immunoglobulin Replacement Therapy in Patients with Primary Antibody Deficiency Among Specialized Nurses in Poland
nork: Dorota Mizera, et al.
Argitaratua: (2024-11-01)

Home-based subcutaneous immunoglobulin G replacement therapy under real-life conditions in children and adults with antibody deficiency
nork: Hoffmann F, et al.
Argitaratua: (2010-06-01)

Successful discontinuation of immunoglobulin G replacement at age 10 in a patient with immunoglobulin G2 deficiency
nork: Masayoshi Shinjoh, et al.
Argitaratua: (2017-10-01)

Fatigue Is Common in Immunoglobulin G Subclass Deficiency and Correlates With Inflammatory Response and Need for Immunoglobulin Replacement Therapy
nork: Per Wågström, et al.
Argitaratua: (2022-01-01)